D.E. Shaw & Co’s NexImmune, Inc. Common Stock NEXI Stock Holding History

D.E. Shaw & Co’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-609	Closed	-$70K	–	6058
2021 Q4	$70K	Buy	+609	New	+$146K	﹤0.01%	5137

Other funds holding NEXI

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allen Operations New York $670M AUM 26.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

D.E. Shaw & Co's NEXI Position: Q1 2022 in Review

D.E. Shaw & Co sold out of NexImmune, Inc. Common Stock (NEXI) in Q1 2022, closing a stake of 609 shares — an estimated $70K sold.

D.E. Shaw & Co first reported a position in NEXI in Q4 2021 and held it in 1 quarter. The position peaked at $70K in Q4 2021. 52 funds tracked by Wall St. Rank hold NEXI as of Q1 2022.

D.E. Shaw & Co reported no remaining NexImmune, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
D.E. Shaw & Co sold 609 NexImmune, Inc. Common Stock shares in Q1 2022, an estimated $70K.
D.E. Shaw & Co first reported a position in NexImmune, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
D.E. Shaw & Co's NexImmune, Inc. Common Stock position peaked at $70K in Q4 2021.
52 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q1 2022.

Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.